Search and analyze individual stocks with comprehensive metrics

Maitreya Medica.

MAITREYAHealthcare Services

Fundamental Score

...

Maitreya Medica. Share Price & Market Analysis

Current Market Price (CMP)
120.65
No change data available
Market Cap
162.62 (Cr)
Industry
Healthcare Services

Profitability Metrics

Poor

Return on Equity

7.17%
Poor

Return on Capital Employed

10.77%
Good

Operating Profit Margin (5Y)

12.21%
Poor

Dividend Yield

0.00%

Valuation Metrics

Poor

Price to Earnings

87.90x

Market Capitalization

162.62 (Cr)

Industry P/E

54.87x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

122.22%
Poor

YoY Quarterly Sales Growth

-3.09%

Sales Growth (5Y)

N/A

EPS Growth (5Y)

N/A

Profit Growth (5Y)

N/A

Financial Health

Good

Debt to Equity

0.39x
Excellent

Interest Coverage

4.99x
Poor

Free Cash Flow (5Y)

-0.26 (Cr)

Ownership Structure

Good

Promoter Holding

73.11%
Poor

FII Holding

0.01%
Poor

DII Holding

0.00%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
73.11%
Promoter Holding
162.62 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of MAITREYA across key market metrics for learning purposes.

Positive Indicators

3 factors identified

Robust Profit Growth (122.22%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Balanced Promoter Holding (73.11%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

8 factors identified

Below-Average Return on Equity (7.17%)

Observation: Returns on equity are below industry benchmarks.

Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.

Premium Valuation Risk (P/E: 87.90x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations. Consider entry timing carefully.

Negative Free Cash Flow (₹-0.26 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

Limited Institutional Interest (FII+DII: 0.01%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

High P/E Ratio

Observation: Stock may be overvalued relative to earnings.

Analysis: P/E above 30 requires strong growth execution to justify current valuations.

Very High P/E Ratio

Observation: Significant overvaluation risk present.

Analysis: Extremely high P/E ratios indicate potential bubble territory and high downside risk.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

📊 Educational Market Overview

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities.

Loading Peer Comparison

Finding companies in the Hospital sector...

Financial Statements

Comprehensive financial data for Maitreya Medica.

About MAITREYA

Company Details

Symbol:MAITREYA
Industry:Healthcare Services
Sector:Hospital

Market Information

Market Cap:162.62 (Cr)
P/E Ratio:87.90
Beta:N/A

Performance

52W High:N/A
52W Low:N/A
Dividend Yield:0.00%

MAITREYA Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)7.17%
Return on Capital Employed10.77%
Operating Profit Margin (5Y)12.21%
Debt to Equity Ratio0.39
Interest Coverage Ratio4.99

Growth & Valuation

Sales Growth (5Y)N/A%
Profit Growth (5Y)N/A%
EPS Growth (5Y)N/A%
YoY Quarterly Profit Growth122.22%
YoY Quarterly Sales Growth-3.09%

Frequently Asked Questions

What is the current price of MAITREYA?

MAITREYA is currently trading at ₹120.65 with a gain of 0.00% today. The current market price (CMP) represents the last traded price of MAITREYA shares on the stock exchange. This price fluctuates throughout trading hours based on supply and demand. You can track real-time price movements, percentage changes, and trading volume in the header section.

What is the P/E ratio of MAITREYA and what does it mean?

MAITREYA has a P/E ratio of 87.90x compared to the industry average of 54.87x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹88 for every ₹1 of annual earnings. This is higher than the industry average, suggesting either growth premium or potential overvaluation.

How is MAITREYA performing according to Bull Run's analysis?

MAITREYA has a Bull Run fundamental score of 28.7/100, which indicates concerns that require careful analysis. This comprehensive rating is based on 15+ financial parameters including profitability (ROE: 7.17%), growth metrics, valuation ratios, and financial health indicators. The score updates quarterly with new financial data and helps you quickly assess overall investment quality.

What sector and industry does MAITREYA belong to?

MAITREYA operates in the Healthcare Services industry. This sector classification helps understand the broader economic trends, regulatory framework, and competitive landscape affecting Maitreya Medica.. Companies in this industry typically face similar market dynamics, cyclical patterns, and macroeconomic factors. Understanding the industry context is crucial for peer comparison and assessing how sector-specific trends might impact the stock's performance.

What is Return on Equity (ROE) and why is it important for MAITREYA?

MAITREYA has an ROE of 7.17%, which suggests challenges in generating returns from shareholders' equity. Return on Equity measures how efficiently Maitreya Medica. generates profits from shareholders' equity. An ROE of 7% means the company generates ₹7 profit for every ₹100 of shareholders' equity. This metric is crucial for assessing management's ability to create value for shareholders.

How is MAITREYA's debt-to-equity ratio and what does it indicate?

MAITREYA has a debt-to-equity ratio of 0.39, which indicates moderate leverage that should be monitored. This means the company has ₹39 of debt for every ₹100 of equity. This conservative approach provides financial stability but may limit growth potential.

What is MAITREYA's dividend yield and is it a good dividend stock?

MAITREYA offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested. The focus appears to be more on growth rather than dividend income. Dividend yield is calculated as annual dividend per share ÷ current share price × 100. Evaluate dividend consistency over 5+ years and free cash flow coverage for sustainability.

How has MAITREYA grown over the past 5 years?

MAITREYA has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth N/A%, and EPS Growth N/A%. These growth metrics show the company's ability to expand its business and improve profitability over time. Sales growth indicates market expansion, profit growth shows operational efficiency, and EPS growth directly impacts share price appreciation potential.

What is the promoter holding in MAITREYA and why does it matter?

Promoters hold 73.11% of MAITREYA shares, with 0.00% of promoter shares pledged. This high promoter holding indicates strong management confidence and alignment with shareholders. Low pledging indicates financial stability of promoters. Recent change in promoter holding: 0.00%.

How does MAITREYA compare with its industry peers?

MAITREYA trades at P/E 87.90x vs industry average 54.87x, with ROE of 7.17% and ROCE of 10.77%. The stock trades at a premium to industry average, which may be justified by superior fundamentals. Peer comparison helps identify whether MAITREYA is outperforming its competitive set in profitability, growth, and valuation metrics.

What is MAITREYA's market capitalization and what category does it fall into?

MAITREYA has a market capitalization of ₹163 crores, making it a Mid-cap stock. Mid-cap stocks balance growth potential with moderate risk. Market cap is calculated as current share price × total outstanding shares, representing the company's total market value.

What are the key financial ratios to consider for MAITREYA?

Key ratios for MAITREYA: ROE 7.17% (Needs improvement), ROCE 10.77%, P/E 87.90x, Debt-to-Equity 0.39, Interest Coverage 4.99x. These ratios help assess profitability (ROE, ROCE), valuation (P/E), financial health (D/E, Interest Coverage), and overall investment quality. Compare these with industry medians and historical trends for meaningful analysis.

How volatile is MAITREYA stock and what is its beta?

MAITREYA has a beta of N/A, which means it is less volatile than the market and offers defensive characteristics. Beta measures price volatility relative to the Nifty 50. Lower beta stocks provide stability during uncertain market conditions. Consider beta alongside your risk tolerance and portfolio diversification strategy.

What is the 52-week high and low for MAITREYA?

MAITREYA has a 52-week high of ₹N/A and low of ₹N/A. Currently trading at ₹120.65, the stock is within its annual trading range. Trading near highs indicates strong momentum but limited upside potential.

What are the key risks associated with investing in MAITREYA?

Key risks for MAITREYA include: Market volatility (Beta: N/A), financial leverage (Debt-to-Equity: 0.39), and operational challenges. The stock has a Fundamental Score of 28.7/100, indicating higher risk requiring thorough due diligence. Sector-specific risks in Healthcare Services include regulatory changes, economic cycles, and competitive pressures. Consider your risk tolerance, investment horizon, and portfolio diversification before investing. Past performance doesn't guarantee future results.

What is MAITREYA's operating profit margin and how has it trended?

MAITREYA has a 5-year average Operating Profit Margin (OPM) of 12.21%, which is good and shows decent operational efficiency. Operating Profit Margin shows operational efficiency by measuring operating profit as a percentage of revenue. Monitor margin trends to assess management's ability to control costs and improve efficiency. Compare with industry peers to understand relative performance.

How is MAITREYA's quarterly performance in terms of sales and profit growth?

MAITREYA's recent quarterly performance shows YoY Sales Growth of -3.09% and YoY Profit Growth of 122.22%. Growth rates indicate the current business trajectory and market demand. Sales growth shows market demand while profit growth reveals operational efficiency and margin management.

What is the FII and DII holding pattern in MAITREYA?

MAITREYA has FII holding of 0.01% and DII holding of 0.00%, totaling 0.01% institutional ownership. This institutional participation level shows the confidence of professional money managers. Monitor quarterly changes in institutional holdings for investment flow trends and sentiment.